Kazuyuki Numakura

24PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMolecular targetsPredictive and prognostic markersInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 16, 2026
Real-World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC.

|Sep 15, 2026
Everolimus-Involving Immunosuppression Attenuates Renal Interstitial Fibrosis Through Modulation of Mammalian Target of Rapamycin-Related Signal Transduction.

|Sep 14, 2026
Treatment Patterns and Outcomes After Recurrence Following Adjuvant Nivolumab for Urothelial Carcinoma: An AGEHA Real-World Study.

|Sep 10, 2026
Primary Resistance to Immune Checkpoint Inhibitor Combination Therapy in Metastatic Renal Cell Carcinoma: Focus on Nivolumab Plus Ipilimumab.

|Aug 15, 2026
Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

|May 31, 2026
Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

Pageof 4

Frequent Collaborators

9 joint publications

Shintaro Narita

5 joint publications

Shingo Hatakeyama

4 joint publications

Syuya Kandori

3 joint publications

Hiroshi Kikuchi